07.27.2021
McKnight’s Senior Living: “Educating or ‘taking a stand’? Associations differ on approach to long-term care worker COVID vaccination”
BioWorld: “Other news to note for July 27, 2021”
07.26.2021
Hebrew SeniorLife: “Hebrew SeniorLife Makes COVID-19 Vaccination a Condition of Employment: Effective October 1, 2021, Requirement Designed to Protect the Health and Safety of Patients, Residents, and Employees”
07.21.2021
FirstWord Pharma: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale”
Le Lezard: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale”
Market Screener: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale: New data shows protein-based AKS-452 vaccine is shelf-stable for six months at 25° C (77° F)”
Opera News: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale”
BioWorld: “Other news to note for July 21, 2021”
BioSpace: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale”
Hebrew SeniorLife: “Hebrew SeniorLife Receives The John A. Hartford Foundation 2021 Business Innovation Award: n4a’s Aging and Disability Business Institute Recognized Hebrew SeniorLife for its Innovative Program that Integrates Health Care Services and Housing” (July 21, 2021)
Akston Bioscience: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-stable COVID-19 Vaccine at Global Scale;New data shows protein-based AKS-452 vaccine is shelf-stable for six months at 25° C (77° F)”
